echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Cell: Why are women more susceptible to Alzheimer's disease? The risk of disease in humans may be closely related to the X chromosome!

    Cell: Why are women more susceptible to Alzheimer's disease? The risk of disease in humans may be closely related to the X chromosome!

    • Last Update: 2022-10-25
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Scientists from Case Western Reserve University and other institutions have shown that women have higher levels of X-linked enzymes called ubiquitin-specific peptidase 11 than men, which may lead to higher
    accumulation of tau protein in the brain.

    Studies of mouse and human brain tissue suggest that there may be a special mechanism that explains sex-based differences in Alzheimer's disease, including why women are more susceptible to Alzheimer's disease
    。 Recently, in a study published in the international journal Cell entitled "X-linked ubiquitin-specific peptidase 11 increases tauopathy vulnerability in women", scientists from Case Western Reserve University and other institutions have shown that compared with men, the female brain is called ubiquitin-specific peptidase 11 (USP11, ubiquitin-specific peptidase 11) has higher levels of X-linked enzymes, which may lead to higher
    accumulation of tau protein in the brain.

    In this study, the researchers established a framework to identify other X-linked factors
    that increase a woman's susceptibility to tauopathy.
    Researchers say women develop Alzheimer's disease about twice as often as men, and the mechanism behind this increased susceptibility is unclear to researchers, and one potential explanation is that women exhibit high levels of tau protein accumulation
    in their brains.

    Why are women more susceptible to Alzheimer's disease? Human risk may be closely related
    to the X chromosome.

    Image source: Cell (2022).
    DOI:10.
    1016/j.
    cell.
    2022.
    09.
    002

    The process of eliminating excess tau protein begins with the addition of a chemical tag called ubiquitin to tau protein, and because this process is abnormal in function leading to abnormal accumulation of tau protein, researchers Kang et al.
    wanted to find out whether increasing or removing ubiquitination tags could increase the activity of
    this enzyme system 。 The researchers found that female mice and humans naturally express high levels of USP11 in the brain, and USP11 levels are also strongly correlated with tau lesions in female (not male) brains, in addition, when the researchers genetically removed USP11 from mouse models of brain tau lesions, female animals were preferentially protected from tau lesions and cognitive impairment of the brain; Males are also protected against tau lesions in the brain, but hardly to the extent of
    females.

    The results suggest that the excessive activity of the USP11 enzyme in females drives their susceptibility to Alzheimer's tau lesions, but the researchers caution that mouse models of tau proteinopathy may not fully reflect sexual dimorphism
    in the pathological manifestations of tau in humans 。 In terms of impact, the good news is that USP11 is an enzyme that has traditionally been pharmacologically inhibited, and we hope to develop a drug that works as soon as possible to protect women from high-risk Alzheimer's disease
    , Kang said.

    Taken together, the results suggest that inhibition of USP11-mediated deubiquitination of tau may provide an effective therapeutic opportunity to protect women from an increased
    risk of Alzheimer's disease and other tau proteinopathies.
    (Bio Valley Bioon.
    com)

    Original source:

    Yan Yan,Xinming Wang,Dale Chaput, et al.
     X-linked ubiquitin-specific peptidase 11 increases tauopathy vulnerability in women, Cell (2022).
    DOI: 10.
    1016/j.
    cell.
    2022.
    09.
    002

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.